Aspect Partners’s Gilead Sciences GILD Stock Holding History

Aspect Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.4K	Hold	177	–	–	0.01%	172
2026 Q2	$22.4K	Hold	177	–	–	0.01%	192
2026 Q1	$24.7K	Hold	177	–	–	0.01%	171
2025 Q4	$21.7K	Buy	177 +15	+9%	+$1.82K	0.01%	188
2025 Q3	$18K	Sell	162 -160	-50%	-$18.2K	0.01%	237
2025 Q2	$35.7K	Buy	322 +156	+94%	+$16.6K	0.02%	172
2025 Q1	$18.6K	Buy	166 +7	+4%	+$722	0.01%	203
2024 Q4	$14.7K	Buy	159 +13	+9%	+$1.17K	0.01%	241
2024 Q3	$12.2K	Hold	146	–	–	0.01%	252
2024 Q2	$10K	Hold	146	–	–	0.01%	267
2024 Q1	$10.7K	Sell	146 -10	-6%	-$769	0.01%	261
2023 Q4	$12.6K	Buy	+156	New	+$12.1K	0.01%	231

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Aspect Partners's GILD Position: Q3 2026 in Review

Aspect Partners held its Gilead Sciences (GILD) position steady in Q3 2026 at 177 shares worth $26.4K. The position accounts for 0.01% of the portfolio, ranked #172.

Aspect Partners first reported a position in GILD in Q4 2023 and has held it in 12 quarters since. The position peaked at $35.7K in Q2 2025. 664 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Aspect Partners held 177 shares of Gilead Sciences worth $26.4K as of Q3 2026.
Aspect Partners left its Gilead Sciences share count unchanged in Q3 2026.
Gilead Sciences made up 0.01% of Aspect Partners's portfolio in Q3 2026, its #172 holding.
Aspect Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 12 quarters since.
Aspect Partners's Gilead Sciences position peaked at $35.7K in Q2 2025.
664 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.